Asgn (ASGN) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Asgn (ASGN) over the last 16 years, with Q3 2025 value amounting to $0.87.
- Asgn's EPS (Weighted Average and Diluted) fell 1792.45% to $0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.96, marking a year-over-year decrease of 2525.25%. This contributed to the annual value of $3.83 for FY2024, which is 1486.5% down from last year.
- As of Q3 2025, Asgn's EPS (Weighted Average and Diluted) stood at $0.87, which was down 1792.45% from $0.67 recorded in Q2 2025.
- In the past 5 years, Asgn's EPS (Weighted Average and Diluted) ranged from a high of $3.97 in Q3 2021 and a low of $0.48 during Q1 2025
- In the last 5 years, Asgn's EPS (Weighted Average and Diluted) had a median value of $1.06 in 2024 and averaged $1.2.
- In the last 5 years, Asgn's EPS (Weighted Average and Diluted) skyrocketed by 30101.01% in 2021 and then crashed by 6372.8% in 2022.
- Asgn's EPS (Weighted Average and Diluted) (Quarter) stood at $1.22 in 2021, then dropped by 8.38% to $1.12 in 2022, then dropped by 7.78% to $1.03 in 2023, then dropped by 10.17% to $0.93 in 2024, then decreased by 6.23% to $0.87 in 2025.
- Its last three reported values are $0.87 in Q3 2025, $0.67 for Q2 2025, and $0.48 during Q1 2025.